Elevated absolute monocyte counts (AMCs) have been reported to indicate poor prognosis for patients with lymphoproliferative disease, including those with follicular lymphoma (FL) receiving various treatments. We evaluated the prognostic impact of AMC in 150 consecutive FL patients who received rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) therapy. Progression-free survival (PFS) did not differ significantly according to the AMC level. Univariate and multivariate analyses did not indicate a prognostic significance of AMC for PFS. Thus, the AMC is not a prognostic factor for FL patients treated with R-CHOP. However, immunochemotherapy might influence the prognostic impact of AMC.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2013.07.015DOI Listing

Publication Analysis

Top Keywords

absolute monocyte
8
follicular lymphoma
8
patients treated
8
rituximab cyclophosphamide
8
cyclophosphamide doxorubicin
8
doxorubicin vincristine
8
vincristine prednisone
8
prognostic impact
8
impact amc
8
amc
5

Similar Publications

: Although a wide range of hematological parameters are used as blood-based inflammatory biomarkers, the role of complete blood count-derived inflammatory biomarkers in infection after acute ischemic stroke (AIS) is modest. Therefore, this study aimed to explore complete blood count-derived inflammatory biomarkers as predictors of infection after AIS. : A single-center retrospective cross-sectional study was carried out at the National Brain Center Hospital Prof.

View Article and Find Full Text PDF

Targeted therapy and immunotherapy drugs for oncology have greater efficacy and tolerability than cytotoxic chemotherapeutic drugs. However, the cutaneous adverse drug reactions associated with these newer therapies are more common and remain poorly predicted. An effective prediction model is urgently needed and essential.

View Article and Find Full Text PDF

Causal association of circulating immune cells with nephrotic syndrome: evidence from a two-sample Mendelian randomization study.

Int Urol Nephrol

December 2024

Department of Emergency, Zhuzhou Hospital Affiliated to Xiangya School of Medicine, Central South University, Zhuzhou, 412007, China.

Objective: Nephrotic syndrome, a debilitating manifestation of kidney disease, often arises from diverse glomerular disorders and is accompanied by notable comorbidities. Despite indications of an immunological etiology, the precise role of immune cells in its pathogenesis remains unclear. This study aimed to elucidate the causal relationships between circulating immune cell phenotypes and nephrotic syndrome using a rigorous bidirectional Mendelian randomization approach.

View Article and Find Full Text PDF
Article Synopsis
  • Researchers examined the link between gut microbiota and Autoimmune Liver Diseases (AILDs) using Mendelian Randomization, a method to infer causal relationships while minimizing bias.
  • Their analysis found that a higher involvement of gut microbiota correlates with increased risk for Autoimmune Hepatitis (AIH) and Primary Sclerosing Cholangitis (PSC), with immune cells mediating part of this risk.
  • The study indicates that understanding these immune mechanisms could help inform preventive strategies for managing AILDs in clinical settings.
View Article and Find Full Text PDF

Introduction: Peripheral monocytes have been reported to correlate with clinical outcomes in various types of malignancies. Previous reports have also shown that acute-phase thrombotic thrombocytopenic purpura (TTP) plasma could induce the activation of monocytes. However, the significance of peripheral blood absolute monocyte count (AMC) in idiopathic TTP remains an unanswered question.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!